Increased prevalence of gynaecological conditions such as infections and cervical and ovarian cancer, which leads to an increase in medical procedures, is expected to increase demand for cervical dilators globally in the near future. The infection with high-risk human papillomaviruses (HPV), an extremely common virus transmitted through sexual contact, is linked to nearly all cervical cancer cases (99%). Cervical cancer is the fourth most common cancer in women, according to the World Health Organization (WHO).

Request For a Sample Copy of This Report @

Data Bridge Market Research analyses that the cervical dilator market which is USD 63.94 million in 2022, is expected to reach USD 79.87 million by 2030, at a CAGR of 2.82% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

A cervical dilator is a specialized surgical tool used to dilate the cervix. The cervical opening is typically narrow unless a woman is in labour before childbirth. Cervical dilators can be used in a variety of medical procedures such as childbirth, gynaecological surgery, induced abortion, PAP smear test, vaginismus treatment, and cervical cutterage such as biopsy. A cervical dilator opens the cervix gently and painlessly, allowing the doctor access to the uterus and fallopian tubes.

North America dominates the cervical dilator market due to the prevalence of cervical and ovarian cancer, the availability of highly skilled surgeons and healthcare, and medical facilities are all major factors contributing to this region's dominance. Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of rising awareness and the development of healthcare infrastructure and other medical investments.

COOPER SURGICAL INC. (U.S.), MEDGYN PRODUCTS INC. (U.S.), Sklar Surgical Instruments (U.S.), Purple Surgical (U.K.), Marina Medical Inc. (U.S.), Pelican Feminine (U.K.), SANYOU Corporation Limited (China), Shanghai Metal Corporation (China), Gynetech Advance (France), MEDESIGN LIMITED (Ireland), Medicta Instruments (U.K.), Panpac Medical Corp. (China)

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475